Literature DB >> 2439495

The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication.

M Hoshino, H Taira, S Hattori, M Kawakita.   

Abstract

Treatment of mouse L929 cells with mouse interferon (IFN) lowered the yield of vesicular stomatitis virus (VSV) in a dose-dependent manner. Accumulation of viral proteins was severely inhibited in IFN-treated cells, whereas cellular protein synthesis was not, indicating that the virus-induced shutoff of cellular protein synthesis was prevented by IFN. In order to identify the major target of IFN action precisely, the effect of IFN treatment on the synthesis of viral RNAs and proteins at various stages during the course of viral replication was examined. Accumulation of viral RNAs late in infection was inhibited, as was the case with viral proteins, but the synthesis of leader RNA and mRNAs early in infection was not significantly inhibited by treatment with a moderate dose of IFN. On the other hand, viral protein synthesis at an early stage of infection was strongly inhibited by IFN. The results indicate that the major target reaction of antiviral action of IFN against VSV multiplication is the translation of viral mRNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439495     DOI: 10.1093/jb/101.3.685

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Differential sensitivity of two related viruses, Newcastle disease virus and Sendai virus, to interferon in mouse Had-2 cells: selective inhibition of translation of NDV mRNA.

Authors:  K Aoki; M Kawakita
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  Isolation and characterization of mouse FM3A cell mutants which are devoid of Newcastle disease virus receptors.

Authors:  T Hara; S Hattori; M Kawakita
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Isolation and characterization of a novel mutant mouse cell line resistant to Newcastle disease virus: constitutive interferon production and enhanced interferon sensitivity.

Authors:  K Aoki; M Oh-hira; M Hoshino; M Kawakita
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.